SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-129390
Filing Date
2024-05-02
Accepted
2024-05-02 16:22:05
Documents
4
Period of Report
2024-05-02

Document Format Files

Seq Description Document Type Size
1 6-K d820168d6k.htm 6-K 9602
2 EX-99.1 d820168dex991.htm EX-99.1 99690
3 GRAPHIC g820168g0503003813589.jpg GRAPHIC 1285
4 GRAPHIC g820168g0503003813964.jpg GRAPHIC 2993
  Complete submission text file 0001193125-24-129390.txt   116534
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 24908696
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)